1. Home
  2. VABK vs SABS Comparison

VABK vs SABS Comparison

Compare VABK & SABS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Virginia National Bankshares Corporation

VABK

Virginia National Bankshares Corporation

HOLD

Current Price

$38.36

Market Cap

206.8M

Sector

Finance

ML Signal

HOLD

Logo SAB Biotherapeutics Inc.

SABS

SAB Biotherapeutics Inc.

HOLD

Current Price

$3.74

Market Cap

201.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
VABK
SABS
Founded
1998
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
206.8M
201.4M
IPO Year
2013
N/A

Fundamental Metrics

Financial Performance
Metric
VABK
SABS
Price
$38.36
$3.74
Analyst Decision
Strong Buy
Analyst Count
0
5
Target Price
N/A
$9.80
AVG Volume (30 Days)
11.0K
654.4K
Earning Date
04-23-2026
03-09-2026
Dividend Yield
3.77%
N/A
EPS Growth
N/A
N/A
EPS
2.45
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$15.57
N/A
Revenue Growth
N/A
N/A
52 Week Low
$34.56
$1.00
52 Week High
$44.50
$6.60

Technical Indicators

Market Signals
Indicator
VABK
SABS
Relative Strength Index (RSI) 44.24 43.61
Support Level $37.01 $3.52
Resistance Level $41.33 $4.16
Average True Range (ATR) 0.93 0.30
MACD -0.01 -0.04
Stochastic Oscillator 42.26 6.62

Price Performance

Historical Comparison
VABK
SABS

About VABK Virginia National Bankshares Corporation

Virginia National Bankshares Corp is a bank holding company which is engaged in the commercial and retail banking business. The bank offers a range of banking and related financial services, including checking accounts, negotiable order of withdrawal accounts, money market deposit accounts, certificates of deposit, individual retirement accounts and other depository services. Its segments include the Bank, VNB Trust and Estate Services, Sturman Wealth Advisors, and Masonry Capital. The Bank's commercial banking activities involve making loans, taking deposits and offering related services to individuals, businesses, and charitable organizations.

About SABS SAB Biotherapeutics Inc.

SAB Biotherapeutics Inc is a clinical stage biopharmaceutical company focused on the development and commercialization of a portfolio of products from its proprietary immunotherapy platform to produce fully targeted human polyclonal antibodies, without using human plasma or serum. The company's novel DiversitAb platform enables the rapid production of large amounts of targeted human polyclonal antibodies, leveraging transchromosomic cattle (Tc Bovine) that have been genetically designed to produce human antibodies (immunoglobulin G) rather than bovine in response to an antigen. Animal antibodies have been made in rabbits, sheep and horses.

Share on Social Networks: